home / stock / gild / gild news


GILD News and Press, Gilead Sciences Inc. From 04/11/24

Stock Information

Company Name: Gilead Sciences Inc.
Stock Symbol: GILD
Market: NASDAQ
Website: gilead.com

Menu

GILD GILD Quote GILD Short GILD News GILD Articles GILD Message Board
Get GILD Alerts

News, Short Squeeze, Breakout and More Instantly...

GILD - Attractive call buying opportunities for Russell 1000 stocks - JPM

2024-04-11 13:51:45 ET More on iShares Russell 1000 Growth ETF: IWF ETF: Solid Track Record, But Looks Overextended Now Attractive call overwriting opportunities for Russell 1000 stocks - JPM The top stocks with selling pressure across the Russell universe - Jefferie...

GILD - Biotech Innovations Paving the Way in Breast Cancer Fight

2024-04-11 09:15:34 ET FN Media Group Presents USA News Group News Commentary Vancouver, BC – April 11, 2024 – USA News Group – The American Cancer Society is projecting 2024 to be the first year ever for the US to have more than 2 mill...

GILD - ClearBridge Value Equity Strategy Q1 2024 Portfolio Manager Commentary

2024-04-10 12:50:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The Strategy outperfor...

GILD - Madrigal announces US launch of NASH/MASH drug Rezdiffra

2024-04-09 10:03:48 ET More on Madrigal Pharmaceuticals Madrigal: Accelerated Rezdiffra Approval Puts It In The NASH Lead Madrigal Wins The 'MASH Dash' And A Chance To Shape The Market Before GLP-1 Challenge Madrigal Pharmaceuticals: Perceived Threat From Eli Lilly I...

GILD - Gilead Sciences to Release First Quarter 2024 Financial Results on Thursday, April 25, 2024

Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its first quarter 2024 financial results and guidance will be released on Thursday, April 25, 2024, after the market closes. At 4:30 p.m. Eastern Time that day, Gilead’s management will host a webcast to discuss the company’s...

GILD - 3 No-Brainer Dividend Stocks to Buy in April

2024-04-06 06:49:00 ET Three Motley Fool contributors have dividends on their minds as the second quarter of 2024 begins. And they think they've found some no-brainer dividend stocks to buy in April. Here's why they like AbbVie (NYSE: ABBV) , Gilead Sciences (NASDAQ: GILD) ,...

GILD - ClearBridge Dividend Strategy Q1 2024 Portfolio Manager Commentary

2024-04-06 06:45:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The market’s ri...

GILD - BABA, HBAN, CMCSA, AGNC, GILD showing five-day downward plunge

2024-04-05 10:47:03 ET Alibaba Group Holding Ltd (BABA) BABA is trading DOWN for the last 4 days, and it at trading at $71.63 with volume of 3,262,589 and a one day change of $-0.32 (-0.44%). Alibaba Group Holding Ltd has a 52-week low of 66.64 and a 52-week high of $103.24. The bus...

GILD - Got $5,000? These 3 High-Yielding Dividend Stocks Are Trading Near Their 52-Week Lows

2024-04-05 08:30:00 ET If you buy a dividend stock that's trading at a reduced price, it gives you the opportunity to take advantage of a higher-than-normal yield, and the chance to profit from a gain should the stock bounce back and recover in value. This is why loading up on dividend st...

GILD - Werewolf Therapeutics: In The Hunt For Success In The Cytokine Space

2024-04-04 16:57:58 ET Summary Werewolf Therapeutics, Inc. develops modified cytokines for cancer treatment, including WTX-124, a modified IL-2, and WTX-330, a modified IL-12. Xilio Therapeutics out-licensed their modified IL-12 to Gilead, but I wouldn't be surprised if Werewolf T...

Previous 10 Next 10